Advertisement
Advertisement
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
73.16
USDSponsored
+0.94
+1.30%
Oct 09, 15:59 UTC -4
Closed
After-Market
74.31
+1.16
+1.58%
TARS Earnings Reports
Positive Surprise Ratio
TARS beat 16 of 24 last estimates.
67%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$186.44M
/-$1.54
Implied change from Q2 26 (Revenue/ EPS)
+7.20%
/+214.29%
Implied change from Q3 25 (Revenue/ EPS)
+57.07%
/+413.33%
Tarsus Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, TARS reported earnings of -0.49 USD per share (EPS) for Q2 26, missing the estimate of -0.19 USD, resulting in a -145.12% surprise. Revenue reached 173.91 million, compared to an expected 173.07 million, with a 0.49% difference. The market reacted with a +6.59% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -1.54 USD, with revenue projected to reach 186.44 million USD, implying an increase of 214.29% EPS, and increase of 7.20% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
FAQ
What were Tarsus Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Tarsus Pharmaceuticals, Inc. Common Stock reported EPS of -$0.49, missing estimates by -145.12%, and revenue of $173.91M, 0.49% above expectations.
How did the market react to Tarsus Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 6.59%, changed from $61.29 before the earnings release to $65.33 the day after.
When is Tarsus Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Tarsus Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 7
analysts, Tarsus Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$1.54 and revenue of $186.44M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.